{"entity":{"type":"insider","cik":"0001301120","url":"/insider/0001301120","json_url":"/insider/0001301120.json","name":"Moreadith Randall","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":47,"n_filings":40,"first":"2005-06-17","last":"2026-03-24","span_basis":"filed_date"},"name_variants":[{"name":"Moreadith Randall","source":"filing","n_filings":40,"first_seen":"2005-06-17","last_seen":"2026-03-24"}],"transactions":[{"id":5931634,"accession":"0001301120-26-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-26-000018","line_url":"/filing/0001301120-26-000018#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":2.8566,"price_display":"2.86","price_state":"stated","total_value":18567.9,"total_display":"18,567.90","total_whole":"18,568","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-23","filed_date":"2026-03-24","scope":"insider"},{"id":5898051,"accession":"0001301120-26-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-26-000016","line_url":"/filing/0001301120-26-000016#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39000.0,"shares_display":"39,000","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":97500.0,"total_display":"97,500.00","total_whole":"97,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-19","filed_date":"2026-03-20","scope":"insider"},{"id":5782940,"accession":"0001301120-26-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-26-000012","line_url":"/filing/0001301120-26-000012#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":3.0277,"price_display":"3.03","price_state":"stated","total_value":19680.05,"total_display":"19,680.05","total_whole":"19,680","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-03","scope":"insider"},{"id":5909371,"accession":"0001301120-26-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-26-000010","line_url":"/filing/0001301120-26-000010#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":3.567,"price_display":"3.57","price_state":"stated","total_value":23185.5,"total_display":"23,185.50","total_whole":"23,186","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-28","filed_date":"2026-01-29","scope":"insider"},{"id":5811868,"accession":"0001301120-26-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-26-000008","line_url":"/filing/0001301120-26-000008#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":2.95,"price_display":"2.95","price_state":"stated","total_value":7375.0,"total_display":"7,375.00","total_whole":"7,375","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-23","scope":"insider"},{"id":5752728,"accession":"0001301120-26-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001301120-26-000006","line_url":"/filing/0001301120-26-000006#line-4","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":6000.0,"total_display":"6,000.00","total_whole":"6,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-21","filed_date":"2026-01-21","scope":"insider"},{"id":5752724,"accession":"0001301120-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-26-000006","line_url":"/filing/0001301120-26-000006#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":3.07,"price_display":"3.07","price_state":"stated","total_value":6140.0,"total_display":"6,140.00","total_whole":"6,140","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-21","scope":"insider"},{"id":6119086,"accession":"0001301120-26-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001301120-26-000004","line_url":"/filing/0001301120-26-000004#line-4","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1084.0,"shares_display":"1,084","price_per_share":2.5031,"price_display":"2.50","price_state":"stated","total_value":2713.3604,"total_display":"2,713.36","total_whole":"2,713","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-14","filed_date":"2026-01-14","scope":"insider"},{"id":6119080,"accession":"0001301120-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-26-000004","line_url":"/filing/0001301120-26-000004#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5416.0,"shares_display":"5,416","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":13540.0,"total_display":"13,540.00","total_whole":"13,540","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-14","scope":"insider"},{"id":6064884,"accession":"0001301120-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-26-000002","line_url":"/filing/0001301120-26-000002#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":2.6887,"price_display":"2.69","price_state":"stated","total_value":34953.1,"total_display":"34,953.10","total_whole":"34,953","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-08","filed_date":"2026-01-09","scope":"insider"},{"id":4379761,"accession":"0001301120-25-000039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-25-000039","line_url":"/filing/0001301120-25-000039#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4100.0,"shares_display":"4,100","price_per_share":2.6,"price_display":"2.60","price_state":"stated","total_value":10660.0,"total_display":"10,660.00","total_whole":"10,660","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-23","filed_date":"2025-12-29","scope":"insider"},{"id":5150832,"accession":"0001301120-25-000037","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-25-000037","line_url":"/filing/0001301120-25-000037#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5673.0,"shares_display":"5,673","price_per_share":2.6737,"price_display":"2.67","price_state":"stated","total_value":15167.9001,"total_display":"15,167.90","total_whole":"15,168","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-22","filed_date":"2025-12-23","scope":"insider"},{"id":4073589,"accession":"0001301120-25-000035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-25-000035","line_url":"/filing/0001301120-25-000035#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3227.0,"shares_display":"3,227","price_per_share":2.9631,"price_display":"2.96","price_state":"stated","total_value":9561.9237,"total_display":"9,561.92","total_whole":"9,562","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-16","filed_date":"2025-12-17","scope":"insider"},{"id":4173695,"accession":"0001301120-25-000033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-25-000033","line_url":"/filing/0001301120-25-000033#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":3.2597,"price_display":"3.26","price_state":"stated","total_value":5541.49,"total_display":"5,541.49","total_whole":"5,541","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-12","filed_date":"2025-12-16","scope":"insider"},{"id":4073587,"accession":"0001301120-25-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-25-000030","line_url":"/filing/0001301120-25-000030#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3555.0,"shares_display":"3,555","price_per_share":3.2404,"price_display":"3.24","price_state":"stated","total_value":11519.622,"total_display":"11,519.62","total_whole":"11,520","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-11","filed_date":"2025-12-12","scope":"insider"},{"id":4498623,"accession":"0001301120-25-000027","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001301120-25-000027","line_url":"/filing/0001301120-25-000027#line-4","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":645.0,"shares_display":"645","price_per_share":3.35,"price_display":"3.35","price_state":"stated","total_value":2160.75,"total_display":"2,160.75","total_whole":"2,161","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-10","filed_date":"2025-12-11","scope":"insider"},{"id":4498616,"accession":"0001301120-25-000027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-25-000027","line_url":"/filing/0001301120-25-000027#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":3.3133,"price_display":"3.31","price_state":"stated","total_value":1987.98,"total_display":"1,987.98","total_whole":"1,988","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-09","filed_date":"2025-12-11","scope":"insider"},{"id":4279477,"accession":"0001301120-25-000025","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001301120-25-000025","line_url":"/filing/0001301120-25-000025#line-4","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":3.5246,"price_display":"3.52","price_state":"stated","total_value":17623.0,"total_display":"17,623.00","total_whole":"17,623","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-04","scope":"insider"},{"id":4279469,"accession":"0001301120-25-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-25-000025","line_url":"/filing/0001301120-25-000025#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":3.9052,"price_display":"3.91","price_state":"stated","total_value":5857.8,"total_display":"5,857.80","total_whole":"5,858","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-02","filed_date":"2025-12-04","scope":"insider"},{"id":5072957,"accession":"0001301120-25-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-25-000023","line_url":"/filing/0001301120-25-000023#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5965.0,"shares_display":"5,965","price_per_share":3.9001,"price_display":"3.90","price_state":"stated","total_value":23264.0965,"total_display":"23,264.10","total_whole":"23,264","shares_owned_after":5965.0,"shares_owned_after_display":"5,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":5202149,"accession":"0001628280-25-054059","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-054059","line_url":"/filing/0001628280-25-054059#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":535.0,"shares_display":"535","price_per_share":3.935,"price_display":"3.94","price_state":"stated","total_value":2105.225,"total_display":"2,105.22","total_whole":"2,105","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-25","scope":"insider"},{"id":5036494,"accession":"0001301120-25-000021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-25-000021","line_url":"/filing/0001301120-25-000021#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":3.7541,"price_display":"3.75","price_state":"stated","total_value":24401.65,"total_display":"24,401.65","total_whole":"24,402","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-19","scope":"insider"},{"id":4459815,"accession":"0001301120-25-000019","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-25-000019","line_url":"/filing/0001301120-25-000019#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":4.1,"price_display":"4.10","price_state":"stated","total_value":26650.0,"total_display":"26,650.00","total_whole":"26,650","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-10","filed_date":"2025-11-12","scope":"insider"},{"id":4379750,"accession":"0001301120-25-000017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-25-000017","line_url":"/filing/0001301120-25-000017#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3398.0,"shares_display":"3,398","price_per_share":4.24,"price_display":"4.24","price_state":"stated","total_value":14407.52,"total_display":"14,407.52","total_whole":"14,408","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-05","filed_date":"2025-11-06","scope":"insider"},{"id":4704748,"accession":"0001301120-25-000015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-25-000015","line_url":"/filing/0001301120-25-000015#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3102.0,"shares_display":"3,102","price_per_share":4.3953,"price_display":"4.40","price_state":"stated","total_value":13634.2206,"total_display":"13,634.22","total_whole":"13,634","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-04","filed_date":"2025-11-05","scope":"insider"},{"id":4208999,"accession":"0001301120-25-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-25-000013","line_url":"/filing/0001301120-25-000013#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5551.0,"shares_display":"5,551","price_per_share":4.9615,"price_display":"4.96","price_state":"stated","total_value":27541.2865,"total_display":"27,541.29","total_whole":"27,541","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-28","filed_date":"2025-10-29","scope":"insider"},{"id":4355646,"accession":"0001301120-25-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-25-000011","line_url":"/filing/0001301120-25-000011#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":949.0,"shares_display":"949","price_per_share":5.1857,"price_display":"5.19","price_state":"stated","total_value":4921.2293,"total_display":"4,921.23","total_whole":"4,921","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-27","filed_date":"2025-10-28","scope":"insider"},{"id":4173692,"accession":"0001301120-25-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-25-000009","line_url":"/filing/0001301120-25-000009#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":4.9672,"price_display":"4.97","price_state":"stated","total_value":32286.8,"total_display":"32,286.80","total_whole":"32,287","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-20","filed_date":"2025-10-21","scope":"insider"},{"id":4173689,"accession":"0001301120-25-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-25-000007","line_url":"/filing/0001301120-25-000007#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4326.0,"shares_display":"4,326","price_per_share":5.2,"price_display":"5.20","price_state":"stated","total_value":22495.2,"total_display":"22,495.20","total_whole":"22,495","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-13","filed_date":"2025-10-14","scope":"insider"},{"id":4430928,"accession":"0001301120-25-000005","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001301120-25-000005","line_url":"/filing/0001301120-25-000005#line-4","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45632.0,"shares_display":"45,632","price_per_share":7.01,"price_display":"7.01","price_state":"stated","total_value":319880.32,"total_display":"319,880.32","total_whole":"319,880","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-26","filed_date":"2025-08-27","scope":"insider"},{"id":4430918,"accession":"0001301120-25-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001301120-25-000005","line_url":"/filing/0001301120-25-000005#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2042.0,"shares_display":"2,042","price_per_share":5.65,"price_display":"5.65","price_state":"stated","total_value":11537.3,"total_display":"11,537.30","total_whole":"11,537","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-08-27","scope":"insider"},{"id":4480650,"accession":"0001708599-25-000097","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001708599-25-000097","line_url":"/filing/0001708599-25-000097#line-4","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2077.0,"shares_display":"2,077","price_per_share":5.1,"price_display":"5.10","price_state":"stated","total_value":10592.7,"total_display":"10,592.70","total_whole":"10,593","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-20","filed_date":"2025-08-20","scope":"insider"},{"id":4480634,"accession":"0001708599-25-000097","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001708599-25-000097","line_url":"/filing/0001708599-25-000097#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2227.0,"shares_display":"2,227","price_per_share":5.25,"price_display":"5.25","price_state":"stated","total_value":11691.75,"total_display":"11,691.75","total_whole":"11,692","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-20","scope":"insider"},{"id":4480629,"accession":"0001708599-25-000095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001708599-25-000095","line_url":"/filing/0001708599-25-000095#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":5.25,"price_display":"5.25","price_state":"stated","total_value":28875.0,"total_display":"28,875.00","total_whole":"28,875","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-14","scope":"insider"},{"id":5058966,"accession":"0001708599-25-000085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001708599-25-000085","line_url":"/filing/0001708599-25-000085#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":5.17,"price_display":"5.17","price_state":"stated","total_value":28435.0,"total_display":"28,435.00","total_whole":"28,435","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-04","filed_date":"2025-08-06","scope":"insider"},{"id":4813753,"accession":"0001708599-25-000080","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001708599-25-000080","line_url":"/filing/0001708599-25-000080#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4196.0,"shares_display":"4,196","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":27274.0,"total_display":"27,274.00","total_whole":"27,274","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-29","filed_date":"2025-07-30","scope":"insider"},{"id":4637137,"accession":"0001708599-25-000078","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001708599-25-000078","line_url":"/filing/0001708599-25-000078#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":5.89,"price_display":"5.89","price_state":"stated","total_value":38285.0,"total_display":"38,285.00","total_whole":"38,285","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-28","filed_date":"2025-07-29","scope":"insider"},{"id":4999526,"accession":"0001708599-25-000074","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001708599-25-000074","line_url":"/filing/0001708599-25-000074#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":5.34,"price_display":"5.34","price_state":"stated","total_value":34710.0,"total_display":"34,710.00","total_whole":"34,710","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-21","filed_date":"2025-07-22","scope":"insider"},{"id":4075818,"accession":"0001708599-25-000071","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001708599-25-000071","line_url":"/filing/0001708599-25-000071#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":32565.0,"total_display":"32,565.00","total_whole":"32,565","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-14","filed_date":"2025-07-17","scope":"insider"},{"id":5098618,"accession":"0001708599-25-000069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001708599-25-000069","line_url":"/filing/0001708599-25-000069#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":5.67,"price_display":"5.67","price_state":"stated","total_value":36855.0,"total_display":"36,855.00","total_whole":"36,855","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-07","filed_date":"2025-07-09","scope":"insider"},{"id":4999507,"accession":"0001708599-25-000067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001708599-25-000067","line_url":"/filing/0001708599-25-000067#line-2","is_derivative":false,"issuer_cik":"0001301120","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001301120","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":5.78,"price_display":"5.78","price_state":"stated","total_value":37570.0,"total_display":"37,570.00","total_whole":"37,570","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-30","filed_date":"2025-07-02","scope":"insider"},{"id":1383179,"accession":"0001181431-05-061290","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-05-061290","line_url":"/filing/0001181431-05-061290#line-2","is_derivative":false,"issuer_cik":"0001118361","issuer_name":"RENOVIS INC","issuer_ticker":"RNVS","issuer_name_source":null,"issuer_url":"/issuer/0001118361","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":13.66,"price_display":"13.66","price_state":"stated","total_value":13660.0,"total_display":"13,660.00","total_whole":"13,660","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-11-10","filed_date":"2005-11-14","scope":"insider"},{"id":1369604,"accession":"0001181431-05-056252","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-05-056252","line_url":"/filing/0001181431-05-056252#line-2","is_derivative":false,"issuer_cik":"0001118361","issuer_name":"RENOVIS INC","issuer_ticker":"RNVS","issuer_name_source":null,"issuer_url":"/issuer/0001118361","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":13.43,"price_display":"13.43","price_state":"stated","total_value":13430.0,"total_display":"13,430.00","total_whole":"13,430","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-10-10","filed_date":"2005-10-11","scope":"insider"},{"id":1390401,"accession":"0001181431-05-051772","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-05-051772","line_url":"/filing/0001181431-05-051772#line-2","is_derivative":false,"issuer_cik":"0001118361","issuer_name":"RENOVIS INC","issuer_ticker":"RNVS","issuer_name_source":null,"issuer_url":"/issuer/0001118361","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":14.2,"price_display":"14.20","price_state":"stated","total_value":14200.0,"total_display":"14,200.00","total_whole":"14,200","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-09-12","filed_date":"2005-09-14","scope":"insider"},{"id":1639366,"accession":"0001181431-05-046645","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-046645","line_url":"/filing/0001181431-05-046645#line-1","is_derivative":false,"issuer_cik":"0001118361","issuer_name":"RENOVIS INC","issuer_ticker":"RNVS","issuer_name_source":null,"issuer_url":"/issuer/0001118361","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":13.3,"price_display":"13.30","price_state":"stated","total_value":13300.0,"total_display":"13,300.00","total_whole":"13,300","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-08-10","filed_date":"2005-08-12","scope":"insider"},{"id":1672786,"accession":"0001181431-05-035420","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-05-035420","line_url":"/filing/0001181431-05-035420","is_derivative":false,"issuer_cik":"0001118361","issuer_name":"RENOVIS INC","issuer_ticker":"RNVS","issuer_name_source":null,"issuer_url":"/issuer/0001118361","owner_cik":"0001301120","owner_name":"Moreadith Randall","owner_display_name":"Moreadith Randall","owner_url":"/insider/0001301120","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5400.0,"shares_display":"5,400","price_per_share":13.347592592592592,"price_display":"13.35","price_state":"stated","total_value":72077.0,"total_display":"72,077.00","total_whole":"72,077","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-06-15","filed_date":"2005-06-17","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":47,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":47,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":47},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001708599","name":"Serina Therapeutics, Inc.","url":"/issuer/0001708599","role":"Officer (Chief Scientific Officer)","n_filings":35,"first_seen":"2025-07-02","last_seen":"2026-03-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001118361","name":"RENOVIS INC","url":"/issuer/0001118361","role":"Officer (Chief Medical Officer)","n_filings":5,"first_seen":"2005-06-17","last_seen":"2005-11-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001301120","retrieved_at":"2026-08-26T19:25:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}